BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $266,289,000 | +21.9% | 3,274,984 | -1.4% | 0.19% | +9.2% |
| Q4 2018 | $218,513,000 | -58.4% | 3,319,863 | -51.3% | 0.17% | +1.2% |
| Q3 2018 | $525,120,000 | +80.3% | 6,811,786 | +72.7% | 0.17% | -12.8% |
| Q2 2018 | $291,230,000 | +32.6% | 3,944,065 | +16.8% | 0.20% | +31.5% |
| Q1 2018 | $219,621,000 | -7.0% | 3,376,701 | -7.6% | 0.15% | -4.5% |
| Q4 2017 | $236,208,000 | +3.6% | 3,654,214 | +0.5% | 0.16% | 0.0% |
| Q3 2017 | $228,104,000 | +3.1% | 3,635,121 | -0.5% | 0.16% | +0.6% |
| Q2 2017 | $221,208,000 | +12.5% | 3,653,922 | -3.6% | 0.16% | +9.9% |
| Q1 2017 | $196,591,000 | +8.1% | 3,790,801 | -7.6% | 0.14% | +3.7% |
| Q4 2016 | $181,937,000 | -10.7% | 4,103,229 | -4.1% | 0.14% | +7.1% |
| Q3 2016 | $203,636,000 | +13.5% | 4,278,058 | +7.9% | 0.13% | -8.0% |
| Q2 2016 | $179,366,000 | +11.2% | 3,966,516 | +1.0% | 0.14% | +11.3% |
| Q1 2016 | $161,306,000 | +63.0% | 3,926,629 | +51.4% | 0.12% | +67.6% |
| Q4 2015 | $98,943,000 | +23.2% | 2,593,514 | +6.1% | 0.07% | +17.5% |
| Q3 2015 | $80,322,000 | -53.5% | 2,445,106 | -1.1% | 0.06% | -48.8% |
| Q2 2015 | $172,836,000 | -8.4% | 2,471,555 | -10.3% | 0.12% | -6.1% |
| Q1 2015 | $188,746,000 | +32.5% | 2,755,423 | +41.8% | 0.13% | +31.0% |
| Q4 2014 | $142,461,000 | -16.4% | 1,943,798 | -18.2% | 0.10% | -17.4% |
| Q3 2014 | $170,468,000 | +19.5% | 2,375,200 | +20.4% | 0.12% | +22.2% |
| Q2 2014 | $142,614,000 | -2.0% | 1,972,536 | -0.3% | 0.10% | -5.7% |
| Q1 2014 | $145,589,000 | -3.3% | 1,978,651 | -8.6% | 0.10% | -2.8% |
| Q4 2013 | $150,635,000 | – | 2,165,856 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |